세계의 비침습성 신경자극장치 시장 보고서(2025년)
Non Invasive Neurostimulation Devices Global Market Report 2025
상품코드 : 1769678
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

비침습적 신경자극장치 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 이 성장 전망은 고령 인구 증가, 웨어러블 신경자극 장치의 사용 확대, 의료비 지출 증가, 정부 지원 정책의 긍정적 영향, 정신 건강 관리 분야에서의 활용 확대 등과 연관되어 있습니다. 주요 신흥 동향으로는 최소 침습 자극 기술로의 전환, 무선 신경자극장치의 혁신, 원격 의료 플랫폼과의 통합 강화, 폐쇄형 루프 시스템의 개발, 개인 맞춤형 신경 자극 접근법의 중요성 증대 등이 있습니다.

신경계 질환의 발생률 증가가 향후 비침습적 신경자극 장치 시장의 성장을 촉진할 것으로 예상됩니다. 신경계 질환은 뇌, 척수, 신경에 영향을 미치는 의료적 상태로, 인지, 운동, 감각 장애 등 다양한 증상을 유발합니다. 이러한 질환의 발생이 증가하는 것은 전 세계 인구의 고령화와 밀접한 관련이 있습니다. 고령화는 점차 신경 기능을 저하시키고, 뇌의 가소성을 감소시키며, 산화 스트레스를 증가시켜 신경학적 문제의 발병 및 진행에 기여하기 때문입니다. 비침습적 신경자극 장치는 신경 반응을 평가하기 위해 표적 자극을 전달하여 신경 장애의 진단에 도움을 줍니다. 이 장치는 비수술적 실시간 평가 방법을 제공하여 진단 정확도를 높이고, 병원과 가정에서 환자 치료를 개선합니다. 예를 들어, 2024년 7월 영국 정부 기관인 국립보건서비스(NHS)는 2024년 6월 30일까지 치매(기억력, 사고력, 일상 활동에 영향을 미치는 진행성 뇌 질환)로 진단받은 환자가 48만 7,432명으로, 2024년 5월 31일 대비 3,155건 증가했다고 보고했습니다. 이 신경계 질환의 증가 추세는 비침습적 신경자극장치 시장 성장에 크게 기여하고 있습니다.

비침습적 신경자극장치 시장 주요 기업들은 치료 효과와 환자 결과를 개선하기 위해 맞춤형 자극 프로토콜과 같은 고급 제품 개발에 집중하고 있습니다. 맞춤형 자극 프로토콜은 개인의 특정 의료 상태, 신경 반응, 치료 목표에 맞게 신경 자극 설정을 조정하여 치료 효과를 극대화하고 부작용을 최소화하는 것을 목표로 합니다. 예를 들어, 2023년 10월 핀란드 기반 의료 기술 기업인 Sooma Medical은 비침습적 경두개 직류 자극(tDCS)을 활용한 가정용 치료를 위한 원격 의료진 모니터링 뇌 자극 시스템을 출시했습니다. 이 혁신적인 솔루션은 의료진이 원격으로 치료 세션을 감독할 수 있도록 하여 우울증과 만성 통증과 같은 신경학적 및 정신 건강 질환을 가진 환자의 접근성과 치료 순응도를 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Non-invasive neurostimulation devices are advanced medical technologies developed to influence neural activity without the need for surgical procedures. These devices utilize external techniques such as electrical, magnetic, or ultrasonic stimulation to focus on particular regions of the nervous system. Their primary objective is to treat neurological and psychiatric disorders like chronic pain, depression, and epilepsy by modifying brain or nerve activity in a safe and efficient manner.

The primary categories of non-invasive neurostimulation devices include transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. TENS involves the use of low-voltage electrical pulses delivered through the skin using electrodes as a method for non-invasive pain relief. These devices are employed across a variety of clinical applications such as pain management, neurological and psychological disorders, among others. They serve different end users including hospitals and clinics, homecare settings, and academic or research institutions.

The non invasive neurostimulation devices market size has grown rapidly in recent years. It will grow from $1.67 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. This growth during the historic period can be credited to a rise in neurological disorder cases, increased awareness about neurostimulation therapies, heightened demand for non-invasive treatment methods, enhanced healthcare infrastructure, and a surge in neuromodulation-related research.

The non-invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The forecasted growth can be linked to the rising aging population, increased use of wearable neurostimulation devices, growing healthcare spending, favorable government initiatives, and broader use in mental health care. Key emerging trends include a transition to minimally invasive stimulation techniques, innovations in wireless neurostimulation devices, greater integration with telehealth platforms, the development of closed-loop systems, and a growing emphasis on personalized neurostimulation approaches.

The increasing prevalence of neurological disorders is expected to propel the growth of the non-invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The growing occurrence of these conditions is closely linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of neurological issues. Non-invasive neurostimulation devices assist in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They provide non-surgical, real-time evaluation methods, improving diagnostic accuracy and enhancing patient care in both clinical and home settings. For example, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia-a progressive brain disorder affecting memory, thinking, and daily activities-by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. This rise in neurological disorders is thereby contributing significantly to the growth of the non-invasive neurostimulation devices market.

Major companies operating in the non-invasive neurostimulation devices market are focusing on developing advanced products such as personalized stimulation protocols to enhance treatment effectiveness and patient outcomes. Personalized stimulation protocols involve tailoring neurostimulation settings to an individual's specific medical condition, neural response, and treatment goals to maximize therapeutic benefits while minimizing side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, introduced a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative solution enables healthcare professionals to supervise therapy sessions remotely, improving accessibility and treatment adherence for patients with neurological and mental health conditions like depression and chronic pain.

In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. This acquisition allowed ElectroCore to expand its portfolio in non-invasive neuromodulation by incorporating NeuroMetrix's Quell pain relief device and DPNCheck diagnostic tool, strengthening its position in the field of bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company that specializes in non-invasive neurostimulation devices.

Major players in the non invasive neurostimulation devices market are Boston Scientific Corporation, Alpha-Stim, Neurosoft Bioelectronics SA, Neuronetics Inc., BrainsWay Ltd., eNeura Inc., MagVenture A/S, Nexstim Plc, Neuroelectrics Barcelona S.L.U., Cefaly Technology, ElectroCore Inc., Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc., Sooma Medical, Aleva Neurotherapeutics SA, NeuroSigma Inc., Mind Alive Inc., TheBrainDriver LLC, and Caputron Medical Products LLC.

North America was the largest region in the non invasive neurostimulation devices market in 2024. The regions covered in non-invasive neurostimulation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-invasive neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non Invasive Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non invasive neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for non invasive neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non invasive neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Non Invasive Neurostimulation Devices Market Characteristics

3. Non Invasive Neurostimulation Devices Market Trends And Strategies

4. Non Invasive Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non Invasive Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

6. Non Invasive Neurostimulation Devices Market Segmentation

7. Non Invasive Neurostimulation Devices Market Regional And Country Analysis

8. Asia-Pacific Non Invasive Neurostimulation Devices Market

9. China Non Invasive Neurostimulation Devices Market

10. India Non Invasive Neurostimulation Devices Market

11. Japan Non Invasive Neurostimulation Devices Market

12. Australia Non Invasive Neurostimulation Devices Market

13. Indonesia Non Invasive Neurostimulation Devices Market

14. South Korea Non Invasive Neurostimulation Devices Market

15. Western Europe Non Invasive Neurostimulation Devices Market

16. UK Non Invasive Neurostimulation Devices Market

17. Germany Non Invasive Neurostimulation Devices Market

18. France Non Invasive Neurostimulation Devices Market

19. Italy Non Invasive Neurostimulation Devices Market

20. Spain Non Invasive Neurostimulation Devices Market

21. Eastern Europe Non Invasive Neurostimulation Devices Market

22. Russia Non Invasive Neurostimulation Devices Market

23. North America Non Invasive Neurostimulation Devices Market

24. USA Non Invasive Neurostimulation Devices Market

25. Canada Non Invasive Neurostimulation Devices Market

26. South America Non Invasive Neurostimulation Devices Market

27. Brazil Non Invasive Neurostimulation Devices Market

28. Middle East Non Invasive Neurostimulation Devices Market

29. Africa Non Invasive Neurostimulation Devices Market

30. Non Invasive Neurostimulation Devices Market Competitive Landscape And Company Profiles

31. Non Invasive Neurostimulation Devices Market Other Major And Innovative Companies

32. Global Non Invasive Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non Invasive Neurostimulation Devices Market

34. Recent Developments In The Non Invasive Neurostimulation Devices Market

35. Non Invasive Neurostimulation Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기